Downloads: 1
| # | Blank 1 | Frequency | Blank 2 | Frequency | |
|---|---|---|---|---|---|
| 1 | 1 | use | 13 | that may decrease psa levels e . g . saw palmetto | 5 |
| 2 | 4 | no use | 2 | that may decrease psa levels within 4 weeks prior to enrollment | 2 |
| 3 | 6 | user | 1 | that may have hormonal anti prostate cancer activity and / or are known to decrease psa levels e . g . saw palmetto within 4 weeks of study drug administration day 1 | 1 |
| 4 | 2 | NA | that may have hormonal anti prostate cancer activity and / or are known to decrease psa levels e . g . saw palmetto or systemic corticosteroids within 6 months of enrollment | 1 | |
| 5 | 3 | NA | 1 | ||
| 6 | 5 | NA | that may decrease psa levels i . e . saw palmetto no washout period required | 1 | |
| 7 | 7 | NA | that may decrease psa levels i . e . saw palmetto or systemic corticosteroid greater than the equivalent of 10 mg of prednisone per day during the 4 weeks prior to screening or plans to initiate treatment with the above during the entire duration of the study | 1 | |
| 8 | 8 | NA | that may have hormonal anti prostate cancer activity and / or are known to decrease psa levels e . g . saw palmetto or systemic corticosteroids greater than the equivalent of replacement steroids or > = equivalent of 10 mg of prednisone per day within 4 weeks of enrollment day 1 visit | 1 | |
| 9 | 9 | NA | that may have hormonal anti prostate cancer activity and / or are known to decrease psa levels e . g . saw palmetto or systemic corticosteroids greater than the equivalent of 10 mg of prednisone per day within 2 weeks of enrollment | 1 | |
| 10 | 10 | NA | that may have hormonal anti prostate cancer activity and / or are known to decrease psa values e . g . saw palmetto or systemic corticosteroids for prostate cancer within 4 weeks of day 29 visit start of enzalutamide and adt | 1 | |
| 11 | 11 | NA | that may have hormonal anti prostate cancer activity and / or are known to decrease psa levels e . g . saw palmetto or systemic corticosteroids greater than the equivalent of 10 mg of prednisone per day within 4 weeks of enrollment | 1 |